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Bisphosphonic acid acts as Gamma/Delta T cell activating antigen 
and has direct cytotoxic activity against pancreatic carcinoma cells
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Background
T cells bearing the Gamma9/Delta2 T cell receptor (TCR)
constitute two to ten percent of peripheral blood T lym-
phocytes. They have recently raised much interest as non-
MHC restricted effector cells against a variety of tumors.
Gamma/Delta T cells are known to be stimulated by phos-
phoantigens without the need of professional antigen pre-
senting cells. Furthermore, it is described that incubation
with phosphoantigens increases their proliferation rate
rapidly.
Materials & Methods
Apoptotic and anti-proliferative effects of two bisphos-
phonates (pamidronate and zoledronic acid) against
eight different ductal pancreatic carcinoma cell lines were
measured by Annexin-V/PI stain and MTT assay. Gamma/
Delta T cells were enriched from peripheral blood of
healthy donors and expanded by stimulation with anti-
CD3 and IL-2. Cytotoxic activity of Gamma/Delta T cells
of age of 14 days was tested against these cell lines. In the
next step, we pulsed tumor cells prior to the 51Cr release
assay with bisphosphonates.
Results
Zoledronic acid induced even at lower concentrations
inhibition of proliferation. Incubation with a 3 µM solu-
tion inhibits proliferation to 11–93%. Cell lines suscepti-
ble for this treatment had a higher apoptosis rate.
Gamma/Delta T cells showed cytotoxic activity against
pancreatic cell lines (cell lysis of 24–37% at an effector to
target ratio of 80:1). Inhibition of proliferation correlated
significantly with susceptibility against Gamma/Delta T
cells (P < 0.003). Pulsing of target cells with bisphospho-
nates prior to the cytotoxicity assay increased the lysis rate
(41–87%).
Discussion
Zoledronic acid has even at concentrations which could
be achieved by normal dosage an anti-proliferative and
apoptotic effect. Cell lines which are susceptible for
bisphosphonates were also susceptible for treatment with
Gamma/Delta T cells. The efficacy of Gamma/Delta T cells
could be further enhanced by pulsing tumor cells with
bisphosphonates.
Conclusion
At least for some pancreatic carcinoma cells a bisphospho-
nate-based therapy maybe useful, particular in combina-
tion with adoptive transfer of Gamma/Delta T cells
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